Intersect ENT, Inc
XENT
XENT was delisted on the 12th of May, 2022.
100 hedge funds and large institutions have $286M invested in Intersect ENT, Inc in 2016 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 38 increasing their positions, 23 reducing their positions, and 29 closing their positions.
749% more call options, than puts
Call options by funds: $4.4M | Put options by funds: $518K
65% more repeat investments, than reductions
Existing positions increased: 38 | Existing positions reduced: 23
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
9% less funds holding
Funds holding: 110 → 100 (-10)
28% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 29
36% less capital invested
Capital invested by funds: $449M → $286M (-$162M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$12.1M |
| 2 |
BC
Broadfin Capital
New York
|
+$11.1M |
| 3 |
Wellington Management Group
Boston,
Massachusetts
|
+$8.63M |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$4.6M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.63M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
-$36.5M |
| 2 |
RIM
RS Investment Management
San Francisco,
California
|
-$22.6M |
| 3 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$6.04M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$5.99M |
| 5 |
GIP
Granite Investment Partners
El Segundo,
California
|
-$5.11M |
XENT Hedge Fund Activity: Q2 2016 in Review
100 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in Intersect ENT, Inc (XENT) for Q2 2016, worth a combined $286M — down 36% from $449M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of XENT and 21 opened new positions — a net loss of 8 holders — while 23 trimmed existing stakes and 38 added.
The largest buyer was Millennium Management, opening a new position worth an estimated $12.1M. The largest seller was Wells Fargo, cutting an estimated $36.5M.
- 100 institutional investors held Intersect ENT, Inc (XENT) as of Q2 2016, down from 110 in Q1 2016.
- Funds reported $286M of Intersect ENT, Inc stock for Q2 2016, down 36% quarter-over-quarter.
- 21 funds opened new Intersect ENT, Inc positions in Q2 2016 and 29 closed out, a net change of -8 holders.
- The largest Intersect ENT, Inc buyer in Q2 2016 was Millennium Management, an estimated $12.1M added.
- The largest Intersect ENT, Inc seller in Q2 2016 was Wells Fargo, an estimated $36.5M sold.
Based on aggregated 13F filings for Q2 2016.